Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Structure Therapeutics Inc. - American Depositary Shares (NQ: GPCR ) 42.45 +0.16 (+0.39%) Streaming Delayed Price Updated: 9:30 AM EDT, Oct 4, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 2,886 Open 42.60 Bid (Size) 42.05 (4) Ask (Size) 42.86 (4) Prev. Close 42.29 Today's Range 42.45 - 42.60 52wk Range 26.61 - 75.02 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News As Weight-Loss Drugs Battle, Upstart Viking Therapeutics Threatens Eli Lilly, Novo Nordisk, Pfizer Today 8:00 EDT Viking Therapeutics is an upstart in the weight-loss drugs space. But it's catching attention. Via Investor's Business Daily Prime Medicine, MINISO Group, Li Auto, Weibo And Other Big Stocks Moving Higher On Monday September 30, 2024 Via Benzinga Performance YTD +5.11% +5.11% 1 Month +11.23% +11.23% 3 Month +12.40% +12.40% 6 Month +8.03% +8.03% 1 Year -22.20% -22.20% More News Read More BioAge Labs, An Obesity Newcomer And Eli Lilly Partner, Rallies 28% On Upsized IPO September 26, 2024 Via Investor's Business Daily Novo Nordisk’s Setback Won’t Last: A Game-Changing Drug Emerges September 24, 2024 Via MarketBeat Peering Into Structure Therapeutics's Recent Short Interest July 15, 2024 Via Benzinga Structure Therapeutics Strengthens Executive Team with Promotion of Blai Coll, M.D., Ph.D. to Chief Medical Officer and Appointment of Ashley Hall, J.D. as Chief Development Officer September 17, 2024 From Structure Therapeutics Inc. Via GlobeNewswire Stock Market Rally Revives; Apple iPhone 16, Nvidia, Oracle, Adobe In Focus: Weekly Review September 13, 2024 Via Investor's Business Daily The 9 Pharma Stocks To Watch — Including Viking, Roche And Amgen — Amid The Fast-Growing Obesity Drug Race August 29, 2024 Via Investor's Business Daily Structure Therapeutics Appoints Angus C. Russell to Board of Directors August 27, 2024 From Structure Therapeutics Inc. Via GlobeNewswire Structure Therapeutics Announces Participation in Upcoming Investor Conferences August 26, 2024 From Structure Therapeutics Inc. Via GlobeNewswire 3 Promising Biotech Stocks for the Long-Term: August 2024 August 13, 2024 Via InvestorPlace GPCR Stock Earnings: Structure Therapeutics Beats EPS for Q2 2024 August 09, 2024 Via InvestorPlace Structure Therapeutics Reports Second Quarter 2024 Financial Results and Recent Highlights August 08, 2024 From Structure Therapeutics Inc. Via GlobeNewswire 3 Biotech Stocks That Could Make Your Summer Unforgettable July 30, 2024 Via InvestorPlace Missed Out on Eli Lilly? These 2 Healthcare Stocks Have Big Catalysts on the Horizon. July 22, 2024 Via The Motley Fool Stock Market Rotation Gets Rough; ASML, Eli Lilly, CrowdStrike, UnitedHealth In Focus: Weekly Review July 19, 2024 Via Investor's Business Daily Why ASLAN Pharmaceuticals Shares Are Trading Lower By Over 38%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session July 17, 2024 Via Benzinga Obesity-Drugs Focused Stocks Tumble On Wednesday - What's Going On With Eli Lilly, Novo Nordisk, Viking Therapeutics, Structure Therapeutics? July 17, 2024 Via Benzinga ASML Reports Q2 Results, Joins Spirit Airlines And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session July 17, 2024 Via Benzinga The 3 Most Undervalued Biotech Stocks to Buy in July 2024 July 12, 2024 Via InvestorPlace Eli Lilly Stock Leads in GLP-1 Race with its Triple Agonist Drug July 09, 2024 Via MarketBeat Altimmune Stock: Is Its GLP-1 Drug the Next Ozempic Killer? July 03, 2024 Via MarketBeat Exposures Product Safety Pfizer Stock is Ready to Stage a Turnaround on GLP-1 Hopes July 02, 2024 Via MarketBeat The 3 Smartest Biotech Stocks to Buy With $5K Right Now June 28, 2024 Via InvestorPlace Could Structure Therapeutics Become the Next Novo Nordisk? June 17, 2024 Via The Motley Fool Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
